Skip to main content
SpringerLink
Log in

The Effect of Gastrointestinal Surgery on Insulin Resistance and Insulin Secretion

  • Lipid and Metabolic Effects of Gastrointestinal Surgery (F Rubino, Section Editor)
  • Published:
Current Atherosclerosis Reports Aims and scope Submit manuscript

Abstract

Diabesity is a term often used to indicate the association of type-2 diabetes mellitus (T2DM) with obesity; the prevalence of both conditions is rapidly increasing worldwide and has reached epidemic proportions. Insulin resistance represents the major determinant of T2DM, which becomes manifest once relative β-cell failure ensues and insulin secretion is no longer sufficient to compensate for insulin resistance. In recent years, gastrointestinal surgery has emerged as the most effective option for the treatment of obesity and diabetes, with level-1 evidence of diabetes remission. Restrictive gastric operations such as gastric banding can improve insulin resistance in proportion to weight loss, while gastrointestinal bypass procedures, such as roux-en-y gastric-bypass (RYGB) and biliopancreatic diversion (BPD), can improve glucose homeostasis even before a significant weight loss is reached, suggesting weight-independent mechanisms of action. Studies comparing RYGB to BPD show that RYGB primarily enhances insulin secretion and reduces hepatic glucose output, whereas BPD rapidly improves glycemia primarily through the normalization of insulin sensitivity. Given the fact that BPD involves a significantly longer bypass of the proximal intestine than RYGB, these data suggest that the exclusion of a greater length of small bowel from the transit of food may cause broader and more profound influence on insulin sensitivity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of outstanding importance

  1. Sims EA, Danforth Jr E, Horton ES, et al. Endocrine and metabolic effects of experimental obesity in man. Recent Prog Horm Res. 1973;29:457–96.

    PubMed  CAS  Google Scholar 

  2. National Heart, Lung and Blood Institute. Morbidity & mortality: 1998 chartbook on cardiovascular, lung, and blood diseases. Rockville, Maryland: US Department of Health and Human Services, National Institutes of Health, 1998.

  3. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–53.

    Article  PubMed  Google Scholar 

  4. Anjum Q. Diabesity- a future pandemic. J Pak Med Assoc. 2011;61:321.

    PubMed  Google Scholar 

  5. NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med. 1991,115:956–961.

    Google Scholar 

  6. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122:248–56.

    Article  PubMed  Google Scholar 

  7. Dorman RB, Serrot FJ, Miller CJ, et al. Case-matched outcomes in bariatric surgery for treatment of type 2 diabetes in the morbidly obese patient. Ann Surg. 2012;255:287–93.

    Article  PubMed  Google Scholar 

  8. Dixon JB, O’Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299:316–23.

    Article  PubMed  CAS  Google Scholar 

  9. Sesti G, Folli F, Perego L, et al. Effects of weight loss in metabolically healthy obese subjects after laparoscopic adjustable gastric banding and hypocaloric diet. PLoS One. 2011;6:e17737.

    Article  PubMed  CAS  Google Scholar 

  10. • Rao RS, Yanagisawa R, Kini S. Insulin resistance and bariatric surgery. Obes Rev 2012;13:316–328. This is a very accurate and thorough systematic review of available data in the literature on behavior of insulin resistance after the different bariatric operations. In addition the Authors discuss critically the various methods of measurement and the mechanisms of improvement of insulin resistance and its relation to the changes of incretins and gastrointestinal hormones.

    Article  PubMed  CAS  Google Scholar 

  11. Scott WR, Batterham RL. Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: understanding weight loss and improvements in type 2 diabetes after bariatric surgery. Am J Physiol Regul Integr Comp Physiol. 2011;301:R15–27.

    Article  PubMed  CAS  Google Scholar 

  12. Hutter MM, Schirmer BD, Jones DB, et al. First report from the American College of Surgeons Bariatric Surgery Center Network: laparoscopic sleeve gastrectomy has morbidity and effectiveness positioned between the band and the bypass. Ann Surg. 2011;254:410–20.

    Article  PubMed  Google Scholar 

  13. •• Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012;366:1567–1576. This is one of the two much-needed, randomized control trials in T2DM patients, which have been published recently, comparing SG and RYGB to intensive medical therapy. At one year follow-up, the surgical groups fared by far much better than medical groups providing level 1 evidence to the role of the surgical option to the treatment of the type 2 obese diabetic patients.

    Article  PubMed  CAS  Google Scholar 

  14. Abbatini F, Rizzello M, Casella G, et al. Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes. Surg Endosc. 2010;24:1005–10.

    Article  PubMed  CAS  Google Scholar 

  15. Stefater MA, Sandoval DA, Chambers AP, et al. Sleeve gastrectomy in rats improves postprandial lipid clearance by reducing intestinal triglyceride secretion. Gastroenterology. 2011;141:939–49.

    Article  PubMed  CAS  Google Scholar 

  16. •• Chambers AP, Jessen L, Ryan KK, et al. Weight-independent changes in blood glucose homeostasis after gastric bypass or vertical sleeve gastrectomy in rats. Gastroenterology. 2011;141:950–958. This experimental study in obese rats after either RYGB or SG was very elegantly designed and was able to demonstrate that the restored glucose homeostasis was in part weight-independent and linked to enhanced GLP-1 and insulin secretion.

    Article  PubMed  CAS  Google Scholar 

  17. Larder R, O’Rahilly S. Shedding pounds after going under the knife: guts over glory-why diets fail. Nat Med. 2012;18:666–7.

    Article  PubMed  CAS  Google Scholar 

  18. •• Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 2012;366:1577–1585. This is one of the two much-needed, prospective randomized trials in T2DM subjects comparing RYGB and BPD to conventional medical therapy. It is to be mentioned that the inclusion criteria were selected following the guidelines indicated by the NIH Consensus Conference of 1991 which, although widely endorsed, were never validated. At two years follow-up the surgical patients outperformed in a very remarkable way the medical group and evidence was provided that neither weight change nor duration of diabetes were not significant predictors of diabetes reversal.

    Article  PubMed  CAS  Google Scholar 

  19. Campos GM, Rabl C, Peeva S, et al. Improvement in peripheral glucose uptake after gastric bypass surgery is observed only after substantial weight loss has occurred and correlates with the magnitude of weight lost. J Gastrointest Surg. 2010;14:15–23.

    Article  PubMed  Google Scholar 

  20. Camastra S, Gastaldelli A, Mari A, et al. Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes. Diabetologia. 2011;54:2093–102.

    Article  PubMed  CAS  Google Scholar 

  21. Nannipieri M, Mari A, Anselmino M, et al. The role of beta-cell function and insulin sensitivity in the remission of type 2 diabetes after gastric bypass surgery. J Clin Endocrinol Metab. 2011;96:E1372–9.

    Article  PubMed  CAS  Google Scholar 

  22. Jorgensen NB, Jacobsen SH, Dirksen C, et al. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with type 2 diabetes and normal glucose tolerance. Am J Physiol Endocrinol Metab 2012 [Epub ahead of print]

  23. Kim MK, Lee HC, Lee SH, et al. The difference of glucostatic parameters according to the remission of diabetes after Roux-en-Y gastric bypass. Diabetes Metab Res Rev 2012 [Epub ahead of print].

  24. Lin E, Liang Z, Frediani J, et al. Improvement in ß-cell function in patients with normal and hyperglycemia following Roux-en-Y gastric bypass surgery. Am J Physiol Endocrinol Metab. 2010;299:E706–12.

    Article  PubMed  CAS  Google Scholar 

  25. Service GJ, Thompson GB, Service FJ, et al. Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med. 2005;353:249–54.

    Article  PubMed  CAS  Google Scholar 

  26. Kellogg TA, Bantle JP, Leslie DB, et al. Postgastric bypass hyperinsulinemic hypoglycemia syndrome: characterization and response to a modified diet. Surg Obes Relat Dis. 2008;4:492–9.

    Article  PubMed  Google Scholar 

  27. Salinari S, Bertuzzi A, Guidone C, et al. Insulin sensitivity and secretion changes after gastric bypass in normotolerant and diabetic obese subjects. Ann Surg 2012, in press.

  28. Kindel TL, Yoder SM, Seeley RJ, et al. Duodenal-jejunal exclusion improves glucose tolerance in the diabetic, Goto-Kakizaki rat by a GLP-1 receptor-mediated mechanism. J Gastrointest Surg. 2009;13:1762–72.

    Article  PubMed  Google Scholar 

  29. Speck M, Cho YM, Asadi A, Rubino F, Kieffer TJ. Duodenal-jejunal bypass protects GK rats from {beta}-cell loss and aggravation of hyperglycemia and increases enteroendocrine cells coexpressing GIP and GLP-1. Am J Physiol Endocrinol Metab. 2011;300:E923–32.

    Article  PubMed  CAS  Google Scholar 

  30. Laferrère B, Teixeira J, McGinty J, et al. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab. 2008;93:2479–85.

    Article  PubMed  Google Scholar 

  31. Laferrère B. Do we really know why diabetes remits after gastric bypass surgery? Endocrine. 2011;40:162–7.

    Article  PubMed  Google Scholar 

  32. Scopinaro N, Marinari GM, Camerini GB, et al. Specific effects of biliopancreatic diversion on the major components of metabolic syndrome: a long-term follow-up study. Diabetes Care. 2005;28:2406–11.

    Article  PubMed  Google Scholar 

  33. Guidone C, Manco M, Valera-Mora E, et al. Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes. 2006;55:2025–31.

    Article  PubMed  CAS  Google Scholar 

  34. Salinari S, Bertuzzi A, Asnaghi S, et al. First-phase insulin secretion restoration and differential response to glucose load depending on the route of administration in type 2 diabetic subjects after bariatric surgery. Diabetes Care. 2009;32:375–80.

    Article  PubMed  CAS  Google Scholar 

  35. Salinari S, Bertuzzi A, Iaconelli A, et al. Twenty-four hour insulin secretion and beta cell NEFA oxidation in type 2 diabetic, morbidly obese patients before and after bariatric surgery. Diabetologia. 2008;51:1276–84.

    Article  PubMed  CAS  Google Scholar 

  36. Mingrone G, Nolfe G, Gissey GC, et al. Circadian rhythms of GIP and GLP1 in glucose-tolerant and in type 2 diabetic patients after biliopancreatic diversion. Diabetologia. 2009;52:873–81.

    Article  PubMed  CAS  Google Scholar 

  37. Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357:753–61.

    Article  PubMed  CAS  Google Scholar 

  38. Lim EL, Hollingsworth KG, Aribisala BS, et al. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia. 2011;54:2506–14.

    Article  PubMed  CAS  Google Scholar 

  39. Kelley DE, Wing R, Buonocore C, et al. Relative effects of calorie restriction and weight loss in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1993;77:1287–93.

    Article  PubMed  CAS  Google Scholar 

  40. Pournaras DJ, Osborne A, Hawkins SC, et al. Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomes. Ann Surg. 2010;252:966–71.

    Article  PubMed  Google Scholar 

  41. Yki-Järvinen H. Type 2 diabetes: remission in just a week. Diabetologia. 2011;54:2477–9.

    Article  PubMed  Google Scholar 

  42. Rubino F, Schauer PR, Kaplan LM. Metabolic surgery to treat type 2 diabetes: clinical outcome and mechanisms of action. Annu Rev Med. 2010;61:393–411.

    Article  PubMed  CAS  Google Scholar 

Download references

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

  1. Department of Surgery, Catholic University of Rome, Largo A. Gemelli 8, 00168, Rome, Italy

    Marco Castagneto

  2. Department of Internal Medicine, Catholic University of Rome, Largo A. Gemelli 8, 00168, Rome, Italy

    Geltrude Mingrone

Authors
  1. Marco Castagneto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Geltrude Mingrone
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Geltrude Mingrone.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Castagneto, M., Mingrone, G. The Effect of Gastrointestinal Surgery on Insulin Resistance and Insulin Secretion. Curr Atheroscler Rep 14, 624–630 (2012). https://doi.org/10.1007/s11883-012-0284-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11883-012-0284-6

Keywords

Search

Navigation